Cells predict onset of graft-versus-host disease in men receiving BMTs from …EurekAlert (press release)Miklos and his associates have shown in other studies that an injectable drug called rituximab (itself an antibody) that attacks B cells while spar…
|
Precio Rituximab será regulado por Comisión en Colombia
Comunicado-Prensa.com (Comunicado de prensa) La Comisión Nacional de Precios de Medicamentos y Dispositivos Médicos del Ministerio de Comercio, Industria y Turismo aprobó el ingreso de Rituximab y otros 80 medicamentos al régimen de control directo de precios. A través de la circular 001 del 30 … |
High-dose Vorinostat effective at treating relapsed lymphomasHutchinson Center A Life of SciencePreclinical studies at Fred Hutch and other research centers have found Vorinostat to be effective when used along with the standard chemotherapy combo, whi…
High-dose Vorinostat effective at treating relapsed lymphomasMedical XpressPreclinical studies at Fred Hutch and other research centers have found Vorinostat to be effective when used along with the standard chemotherapy combo, which is known by the ac…
Clinical Notes: HCV, Interferon, and HedgehogsMedPage TodayA drug with a mechanism of action similar to rituximab (Rituxan) but that may be more effective met its primary endpoint in the first part of a phase III trial, said its manufacturer. Compared …
|
Roche’s obinutuzumab significantly improves PFS in chronic lymphocytic leukemia
The Pharma Letter … with its investigational cancer drug obinutuzumab met its primary endpoint and an additional futility analysis suggested that it could show superiority compared to the company’s currently marketed MabThera/Rituxan (rituximab) in first line chronic … |
|
US biotechs “lobbying states to restrict access to biosimilars”
PharmaTimes “The big drug companies are targeting generic versions of such important brands as Humira [adalimumab] and Enbrel [etanercept], which treat rheumatoid arthritis, and Herceptin [trastuzumab], Avastin [bevacizumab] and Rituxan [rituximab], which target … |
USP sets up three new expert committees for its medicines compendiumpharmabiz.comAlso recently authorised is a monograph for rituximab, a monoclonal antibody used in the treatment of lymphoma, rheumatoid arthritis and other autoimmune disorders. This m…
Monoclonal Antibody Industry 2013 Global and China Market Analysis in New …Genetic Engineering News (press release)In 2011, the sales of six monoclonal antibody agents as Infliximab (Johnson & Johnson), Etanercept (Amgen), Bevacizumab (Roche), Ri…
Cord blood transplantation may cause fatal autoimmune diseaseHealioSteroids, rituximab (Rituxan, Genentech) and cyclosporine were the drugs most frequently used to treat hematological diseases. At a median follow-up of 26 months (range, 2 to 91 months)…